Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation

Pure red cell aplasia (PRCA) following allogeneic hematopoietic stem cell transplantation (HSCT) has been mostly reported in situations involving major ABO incompatibility between donor and recipient. Conventional treatments such as plasma exchange, erythropoietin, and steroid are often unsatisfacto...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Sung-Hoon Jung, Jae-Sook Ahn, Deok-Hwan Yang, Hyung Chul Park, Soo-Young Bae, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Karger Publishers 2012-02-01
Sarja:	Case Reports in Oncology
Aiheet:	Rituximab ABO compatibility Pure red cell aplasia Allogeneic stem cell transplantation
Linkit:	http://www.karger.com/Article/FullText/337022
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!